Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic dinucleotides as anticancer agents

Cyclic dinucleotides as anticancer agents

US Patent 11660311 · Granted May 30, 2023

Estimated economic value: $802,109,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alph2025
Modulators of BCL6 as ligand directed degraders2025
Substituted carbazole compounds2025
Substituted phenyl oxazolone compounds2025
Substituted phenyl oxazolone compounds2025
Substituted indole ether compounds2024
Agonists of ROR GAMMAt2024
Agonists of ROR GAMMAt2024
Agonists of ROR GAMMAt2024
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds2024
Cyclic dinucleotides as anticancer agents2024
Cyclic dinucleotides as anticancer agents2024